An Open-Label, Multicenter, Phase II Trial of ABI-007 (A Cremophor-Free, Protein Stabilized, Nanoparticle Paclitaxel) in Previously Treated Patients With Metastatic Melanoma
Phase of Trial: Phase II
Latest Information Update: 18 Dec 2013
At a glance
- Drugs Paclitaxel (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 19 Sep 2005 New trial record.